A detailed history of First Hawaiian Bank transactions in Incyte Corp stock. As of the latest transaction made, First Hawaiian Bank holds 16,100 shares of INCY stock, worth $1.19 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
16,100
Previous 16,112 0.07%
Holding current value
$1.19 Million
Previous $1.07 Million 4.41%
% of portfolio
0.04%
Previous 0.03%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 08, 2025

SELL
$65.08 - $83.38 $780 - $1,000
-12 Reduced 0.07%
16,100 $1.11 Million
Q3 2024

Oct 04, 2024

SELL
$57.33 - $68.61 $57,559 - $68,884
-1,004 Reduced 5.87%
16,112 $1.07 Million
Q2 2024

Jul 02, 2024

SELL
$51.18 - $63.75 $153 - $191
-3 Reduced 0.02%
17,116 $1.04 Million
Q1 2024

Apr 05, 2024

SELL
$56.55 - $66.59 $39,302 - $46,280
-695 Reduced 3.9%
17,119 $975,000
Q4 2023

Jan 08, 2024

SELL
$52.16 - $64.19 $31,295 - $38,514
-600 Reduced 3.26%
17,814 $1.12 Million
Q3 2023

Oct 10, 2023

SELL
$57.77 - $65.93 $179,087 - $204,383
-3,100 Reduced 14.41%
18,414 $1.06 Million
Q1 2023

Apr 18, 2023

SELL
$70.23 - $86.01 $93,265 - $114,221
-1,328 Reduced 5.81%
21,514 $1.55 Million
Q4 2022

Jan 12, 2023

BUY
$67.18 - $84.11 $1,276 - $1,598
19 Added 0.08%
22,842 $1.83 Million
Q3 2022

Oct 05, 2022

SELL
$66.18 - $82.86 $1,522 - $1,905
-23 Reduced 0.1%
22,823 $1.52 Million
Q2 2022

Jul 22, 2022

BUY
$66.18 - $83.18 $206,680 - $259,771
3,123 Added 15.83%
22,846 $1.74 Million
Q1 2022

Apr 06, 2022

BUY
$66.02 - $79.71 $256,421 - $309,593
3,884 Added 24.52%
19,723 $1.57 Million
Q4 2021

Jan 12, 2022

BUY
$63.34 - $74.11 $1 Million - $1.17 Million
15,839 New
15,839 $1.16 Million
Q3 2021

Oct 12, 2021

SELL
$68.67 - $84.02 $336,620 - $411,866
-4,902 Closed
0 $0
Q2 2021

Jul 08, 2021

BUY
$79.87 - $87.53 $33,385 - $36,587
418 Added 9.32%
4,902 $412,000
Q1 2021

Apr 09, 2021

BUY
$76.02 - $100.5 $19,005 - $25,125
250 Added 5.9%
4,484 $365,000
Q4 2020

Jan 12, 2021

BUY
$80.74 - $97.7 $7,266 - $8,793
90 Added 2.17%
4,234 $369,000
Q3 2020

Oct 06, 2020

SELL
$85.07 - $109.69 $564,099 - $727,354
-6,631 Reduced 61.54%
4,144 $372,000
Q2 2020

Aug 05, 2020

BUY
$74.18 - $108.93 $212,822 - $312,520
2,869 Added 36.29%
10,775 $1.12 Million
Q1 2020

Apr 21, 2020

BUY
$63.18 - $85.97 $33,738 - $45,907
534 Added 7.24%
7,906 $579,000
Q4 2019

Jan 13, 2020

SELL
$73.04 - $95.72 $201,590 - $264,187
-2,760 Reduced 27.24%
7,372 $644,000
Q3 2019

Oct 03, 2019

BUY
$72.82 - $86.52 $207,609 - $246,668
2,851 Added 39.16%
10,132 $752,000
Q2 2019

Jul 15, 2019

BUY
$73.52 - $88.7 $3,823 - $4,612
52 Added 0.72%
7,281 $619,000
Q1 2019

Apr 02, 2019

BUY
$63.56 - $88.17 $457,377 - $634,471
7,196 Added 21806.06%
7,229 $622,000
Q3 2018

Oct 16, 2018

BUY
$61.75 - $74.23 $2,037 - $2,449
33 New
33 $2,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.5B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track First Hawaiian Bank Portfolio

Follow First Hawaiian Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Hawaiian Bank, based on Form 13F filings with the SEC.

News

Stay updated on First Hawaiian Bank with notifications on news.